Document Detail

Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.
MedLine Citation:
PMID:  23089489     Owner:  NLM     Status:  Publisher    
Mutations of components of the mitogen-activated protein kinase pathway, mainly BRAF, are common in serous ovarian borderline tumors, whereas high-grade serous ovarian carcinomas rarely show this feature. With the advent of specific kinase inhibitors active against BRAF-mutated cancers, rapid and sensitive detection of the BRAF V600E, by far the most common mutation of this gene, is of great practical relevance. Currently, BRAF mutations are detected by DNA-based techniques. Recently, a monoclonal antibody (VE1) specific for the BRAF V600E protein suitable for archival tissues has been described. In this study, we compared detection of the V600E mutation in serous ovarian tumors by VE1 immunostaining and by allele-specific polymerase chain reaction. All 141 cases of high-grade serous ovarian cancer showed negative or rarely weak, diffuse background VE1 immunostaining, and BRAF wild type was confirmed by molecular analysis in all tested cases. In contrast, 1 (14%) of 7 low-grade serous carcinomas and 22 (71%) of 31 serous borderline tumors revealed moderate to strong VE1 positivity. Immunostaining was clearly evaluable in all cases with sufficient tumor cells, and only rare cases with narrow cytoplasm were difficult to interpret. The V600E mutation was confirmed by allele-specific polymerase chain reaction and sequencing in all VE1-positive cases. Two VE1-positive cases with low epithelial cell content required repeat microdissection to confirm the presence of the mutation. Immunohistochemistry with the VE1 antibody is a specific and sensitive tool for detection of the BRAF V600E mutation in serous ovarian tumors and may provide a practical screening test, especially in tumor samples with low epithelial content.
Hans Bösmüller; Anna Fischer; Deborah L Pham; Tanja Fehm; David Capper; Andreas von Deimling; Irina Bonzheim; Annette Staebler; Falko Fend
Related Documents :
24474919 - A case of autosomal recessive woolly hair/hypotrichosis with alternation in severity: d...
24707269 - A novel mutation of the gne gene in distal myopathy with rimmed vacuoles: a case with i...
24935469 - The association of phosphatase and tensin homolog deleted on chromosome 10 polymorphism...
23051629 - Predictors of braf mutation in melanocytic nevi: analysis across regions with different...
24995509 - Hif1a as a major vegf regulator: do its polymorphisms have an association with amd?
12687559 - The contribution of genotypes at the mefv and saa1 loci to amyloidosis and disease seve...
7580269 - Screening for pit1 abnormality by pcr direct sequencing method.
11353449 - Systematic search for mutations in the human tissue inhibitor of metalloproteinases-3 (...
21564839 - New polymorphic microsatellite loci in the house sparrow, passer domesticus.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-19
Journal Detail:
Title:  Human pathology     Volume:  -     ISSN:  1532-8392     ISO Abbreviation:  Hum. Pathol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421547     Medline TA:  Hum Pathol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Department of Pathology, Krankenhaus Barmherzige Schwestern Linz, Austria; Institute of Pathology, Tübingen, Germany. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diagnosis, treatment, and long-term outcomes of fetal hydrocephalus.
Next Document:  Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilatera...